Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sagent Turns Generic Injectable Shortages Into Business Opportunity

This article was originally published in The Pink Sheet Daily

Executive Summary

The specialty generic manufacturer has a facility dedicated to producing shortage drugs, a seemingly endless commercial opportunity given the development, regulatory and reimbursement challenges in the sterile injectable space.

You may also be interested in...



Cheap Drugs Create Quality Temptations, FDA Official Says

FDA will focus on enforcing quality standards, but remains aware of its indirect influence on pricing.

Cheap Drugs Create Quality Temptations, FDA Official Says

FDA will focus on enforcing quality standards, but remains aware of its indirect influence on pricing.

Deal Watch: Tax Policy Changes Claiming Victims Already, As Salix/Cosmo Plans Abandoned

Abandoned deals were the order of the week as the Salix/Cosmo breakup followed Novartis’ exit from hepatitis C drug development and a partnership in that space with Enanta. J&J, however, increased its bet on HCV by acquiring Alios, one of several noteworthy buyouts occurring during the week.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS077316

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel